I believe the toughest thing for a pharmaceutical is to get FDA approval.

 

$Sgyp has done just that.

 

Now it is a question of marketing.  

 

Their tested and approved product Trulance , has minor side effects as opposed to current medications. It helps people suffering from IBS and or CIC ,.

 

While no one likes to talk about POOP maybe it is okay to talk about money from helping people poop and while " hope is not a strategy" it is okay to think that perhaps this equity won't take a poop. 

 

http://seekingalpha.com/article/4057211-synergy-pharmaceuticals-sgyp-presents-oppenheimer-27th-annual-healthcare-conference

Right now this stock is a bit beaten down which for me is perplexing but not withstanding  a long opportunity. 

 

 Do your own due diligence .  Best trading